AstraZeneca gets orphan drug designation for pancreatic cancer drug Lynparza Medical Dialogues Bureau24 March 2020 6:00 AM GMTUK: AstraZeneca has announced that Lynparza (olaparib) has been granted orphan drug designation (ODD) in Japan for the maintenance treatment of germlin...
TG Therapeutics gets USFDA Orphan Drug Designation for follicular lymphoma drug Umbralisib Medical Dialogues Bureau9 March 2020 5:15 AM GMTNew York - TG Therapeutics, Inc.today announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation to umbralisib, t...
